Treatment
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
From the Editor-in-Chief
Cancer Treatment: Can Less Be More?Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.
by William G. Nelson, MD, PhD
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
-
Forward Look
Is Immunotherapy Safe in People With HIV?Study supports the use of immune checkpoint inhibitors in an understudied population.
by Carolyn Bernhardt
-
Controlling Peripheral NeuropathyResearchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.
by Cameron Walker
-
Moving the Needle on Metastatic Breast CancerMetastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
by Erin O’Donnell
-
Finding Answers in Prostate CancerPSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
